In the mammary gland during puberty, availability of the chemokine CCL7 is controlled by a 15 scavenging receptor ACKR2 and provides a key signal to macrophages which have the 16 receptor CCR1. Together, this controls the timing of development. 17
The mammary gland develops through branching morphogenesis, giving rise to ductal 49 epithelial networks. In the mouse this process begins at around 3 weeks (MM Richert, KL 50 Schwertfeger, JW Ryder, 2000), when highly proliferative structures known as terminal end 51 buds (TEBs) form at the end of epithelial ducts and drive network formation. Supporting this 52 process is a stromal population containing fibroblasts, extracellular matrix (ECM), adipocytes 53 and immune cells (Wiseman and Werb, 2002) . Prominent amongst the stromal immune cells 54 are macrophages which are found throughout the gland and surrounding TEBs. 55
Macrophages have been implicated in numerous developmental processes (Wynn, Chawla 56 and Pollard, 2013) , and mammary gland development is severely impaired in macrophage-57 deficient mice with altered TEB formation, ductal elongation during puberty and lobuloalveoli 58 development in pregnancy (Pollard and Hennighausen, 1994 ; Gouon-Evans, Rothenberg 59 and Pollard, 2000) . Overall these studies indicate a key role for macrophages in the 60 regulation of ductal branching in the developing mammary gland. 61
62
Macrophages are recruited in a dynamic manner into the mammary gland throughout 63 development (Coussens and Pollard, 2011) . The molecular mechanisms regulating the intra-64 gland movement of macrophages as they migrate to terminal end buds to mediate their 65 developmental effects, are not currently understood and insights into these mechanisms will 66 enhance our overall understanding of how macrophages control mammary gland 67 development. Chemokines which comprise a family of proteins characterised by a conserved 68 cysteine motif, are important in vivo regulators of macrophage intra-tissue dynamics. The 69 chemokine family is subdivided into CC, CXC, XC and CX3C sub-families according to the 70 cysteine distribution, and chemokines act through G-protein coupled receptors to mediate 71 leukocyte migration (Nibbs and Graham, 2013) . Within tissues chemokine distribution, and 72 gradients, can be regulated by members of the atypical chemokine receptor (ACKR) family, 73 which are 7-transmembrane spanning receptors that lack classical signalling responses to 74 ligands and which are typically stromally-expressed (Nibbs and Graham, 2013) . Therefore, 75 together, signalling chemokine receptors and ACKRs regulate intra-tissue chemokine 76 function and coordinate leukocyte migration. 77
78
We have a long-standing interest in one of the atypical chemokine receptors, ACKR2. 79 ACKR2 scavenges and degrades inflammatory CC-chemokines thereby regulating their 80 intra-tissue concentration and spatial distribution (Nibbs and Graham, 2013) . Accordingly it is 81 a key player in the resolution of the inflammatory response with implications for 82 autoimmunity and cancer (Nibbs et al., 2007; Di Liberto et al., 2008; Shams et al., 2017) . We 83 previously demonstrated a role for ACKR2 in regulating branching morphogenesis in the 84 developing lymphatic system via control of macrophage dynamics around developing 85 vessels. More recently we have shown that ACKR2 also regulates branching morphogenesis 86 in the mammary gland and ACKR2-/-mice display precocious mammary gland development. 87
In essence, ACKR2 deficiency results in increased levels of monocyte and macrophage 88 attracting chemokines in the developing mammary gland and this is associated with 89 dysregulation of macrophage numbers and accelerated branching morphogenesis. The 90 chemokines scavenged by ACKR2 are ligands for the signalling chemokine receptors CCR1, 91 CCR2, CCR3, CCR4 and CCR5 ( Fig. 1 Ductal branching in the pubertal mammary gland is regulated by CCR1. 110
To determine involvement of CCR1, CCR3 and CCR5 in the regulation of ductal branching 111 morphogenesis in the mammary gland we analysed carmine alum stained whole-mounts of 112 mammary glands from 7 week old WT and CCR1-/-, CCR3-/-and CCR5-/-mice ( Fig. 2ai-iii) . 113
The individual receptor deficient mice have different genetic backgrounds, therefore mice 114 from each strain were compared to their specific WT (Douglas P . 115
Quantitative analysis of the whole-mounts indicated that branched area, ductal elongation, 116 TEB number and width were unaffected in CCR3-/-and CCR5-/-mice ( Fig. 2aii -iii, 117 Supplementary Fig. 1 ). In contrast, CCR1-/-mice exhibited delayed mammary gland 118 development with decreased branched area at 7 and 8 weeks, reduced ductal elongation 119 and decreased number and width of TEBs at 7 weeks ( Fig. 2ai and bi-iv). In addition, in 120 comparison to WT mice, CCR1-/-mice had thinner branches at 8 weeks ( Fig. 2bv ). This was 121 not seen for CCR3-/-or CCR5-/-mice ( Supplementary Fig. 1e ). As observed for ACKR2-/-122 mice, by 12 weeks, when TEBs have regressed and ductal outgrowth is completed, 123 branched area and ductal elongation are equivalent between WT and CCR1-/-mice ( Fig.  124 2bi-ii). Together these data show that CCR1 regulates mammary gland development at a 125 time point coincident with ACKR2 function in the same context. 126
Of note, in contrast to ACKR2-/-mice, no difference was observed in the distance between, 127 or density of, branches in WT and CCR1-/-mammary glands at any of the time points 128 investigated ( Supplementary Fig. 2 ). This suggests that CCR1 does not regulate the density, 129 but the spread of the ductal network. 130 Importantly, previous publications have suggested potential redundancy in roles for CCR1, 3 131 6 test for any potential redundancy between the CCRs, mammary gland whole-mounts were 135 obtained from iCCR-/-mice which have a compound deletion of CCR1, CCR2, CCR3 and 136 CCR5 (Douglas P Dyer et al., 2019). As observed in the absence of CCR1, iCCR-/-mice 137 display similar delayed development at 7 weeks as demonstrated by reduced TEB number 138 ( Supplementary Fig. 1c ). No additional combinatorial effects of the receptors were observed 139 indicating that CCR1 is a non-redundant regulator of mammary gland development. 140 141 CCR1 and ACKR2 are expressed surrounding epithelium in the mammary gland. 142
We next examined the expression patterns of CCR1 and ACKR2 within the developing 143 mammary gland during late puberty. We used flow cytometry to identify the cell type(s) 144 expressing CCR1 within the mammary gland. As currently available antibodies to murine 145 CCR1 are of limited quality we included cells from CCR1-/-mice as a control. This analysis 146 demonstrated that CCR1 is only detectable on macrophages (CD45+SiglecF-147 CD11b+F4/80+) within the mammary gland ( Fig. 3a ) and further in situ hybridisation showed 148 the CCR1+ cells to be intimately associated with the ductal epithelium ( Fig. 3b ). In contrast 149 to macrophages, eosinophils (CD45+ SiglecF+) and stromal and epithelial (CD45-) cells did 150 not express CCR1 ( Fig. 3a ). We next examined ACKR2 expression in the mammary gland. 151
Previously, we showed that ACKR2 is expressed by stromal fibroblasts in the developing 152 virgin mammary gland (Wilson et al., 2017) . Here we have used in situ hybridisation to locate 153 expression of ACKR2 to stromal cells in the vicinity of the ductal epithelium. Importantly no in 154 situ hybridisation signals were seen in the stroma of CCR1-/-or ACKR2-/-mammary glands 155 ( Fig. 3b ). 156
These data therefore demonstrate that CCR1 and ACKR2 are expressed in distinct cell 157 types surrounding TEBs in the developing mammary gland. 158
159
Estrogen induces CCR1 expression on macrophages.
7
We next examined regulation of CCR1 expression on mammary gland macrophages. 161
Estrogen is essential for mammary gland development and ductal epithelial growth and 162 proliferation (Russell C. Hovey, Josephine F. Trott, 2002). ELISA-based analysis of estradiol 163 levels in the plasma of the developing mouse indicated that its production rises over the 164 same time-frame in which we observe altered ductal development in CCR1-/-mammary 165 glands ( Fig. 4a ). Notably, there was no difference in the levels of estradiol in WT and 166 ACKR2-/-mice, suggesting that the accelerated branching in ACKR2-/-mice is not caused 167 by increased levels of estrogen. To determine whether estrogen regulates CCR1 expression 168 on mammary gland macrophages we enzymatically digested mammary glands and exposed 169 the cells to DMSO (vehicle control) or 17β-estradiol for 1h at 37°C. CCR1 expression was 170 analysed by flow cytometry and shown to increase on CD45+ CD11b+F4/80+ macrophages 171 in response to 17β-estradiol ( Fig. 4b ). There was no significant difference between the level 172 of CCR1 expression on WT and ACKR2-/-macrophages after exposure, indicating that 173 ACKR2 does not regulate this process. 174
To determine whether this was a direct effect of estradiol on mammary gland macrophages, 175
CD11b+F4/80+ cells were isolated by FACS. In the absence of other cell types, CCR1 176 expression was increased following exposure to 17β-estradiol indicating that estrogen 177 induction of CCR1 results from a direct effect on mammary gland macrophages ( Fig. 4c ). 178
Notably, upregulation of CCR1 on macrophages in response to estradiol is age dependent, 179
as there is no difference in CCR1 expression in mice older than 8 weeks ( Fig. 4d ). In 180 addition, 17β-estradiol has no effect on macrophages isolated from the male fat pad or the 181 peritoneum of pubertal female mice ( Fig. 4d-e ). Taken together, this suggests that the effect 182 of estrogen on CCR1 expression is restricted to pubertal mammary gland macrophages and 183 limited to the key developmental time-frame we have identified. 184
185
Chemokine levels are altered in the absence of CCR1 and ACKR2. 186 8 To identify the specific chemokines involved in regulating mammary gland development 187 through CCR1 and ACKR2, multiplex protein analysis of mammary gland lysates was carried 188 out. In keeping with our previous data we showed that, in the absence of scavenging by 189 ACKR2, the chemokines CCL7, CCL11 and CCL12 accumulate in the mammary gland at 6-190 7 weeks ( Fig. 5a ) (Wilson et al., 2017) . The current analysis further revealed elevated CCL3, 191 CCL19, CCL22 and CXCL10 in the ACKR2 -/-mammary gland over this time-frame ( Fig.  192 5a). Notably, other key chemokines associated with monocyte and macrophage migration 193
i.e. CCL2 and CCL5 are unchanged in the ACKR2-/-mammary gland (Fig. 5a ). Importantly, 194 there were no significant differences in the levels of these chemokines in lysates obtained 195 from male WT and ACKR2-/-inguinal fat pads, indicating that the changes observed in 196 female lysates are specifically associated with the mammary gland ( Supplementary Fig. 3) . 197
In CCR1-/-mice, the levels of CCL7, CCL11 and CCL12 were unchanged, indicating that 198 ACKR2 is functional in these mice and able to scavenge chemokines normally. CCL3, 199 CCL19, CCL22, CXCL1 and CXCL12 are increased in ACKR2-/-mice and decreased in 200 CCR1-/-mice ( Fig. 5) . Given that CCL19, CXCL1 and CXCL12 are not ligands for either 201 ACKR2 or CCR1, it is likely that, along with CCL3 and CCL22, their altered levels reflect 202 variation in the numbers of chemokine-expressing immune or epithelial cells within the 203 mammary gland. 204 205 CCR1 and ACKR2 reciprocally regulate CD206+ macrophages within the mammary 206
gland. 207
Reciprocal regulation of leukocyte dynamics by CCR1 and ACKR2 in the developing 208 mammary gland should be reflected in complimentary changes in levels of key cellular 209 populations in CCR1-/-and ACKR2-/-mice. We detected no significant differences in the 210 lymphocyte populations or in non-macrophage myeloid cell populations investigated. 211 However, differences in a key macrophage population were identified. To investigate the 212 effects of CCR1 deficiency on macrophage levels in the mammary gland, flow cytometry of 213 enzymatically digested 6.5 week old WT and CCR1-/-glands was carried out. The gating 214 strategy employed is described in Supplementary Fig. 4 . CCR1-/-mice displayed no 215 significant differences in the bulk macrophage population (CD45+CD11b+F4/80+) ( Fig. 6ai  216 and bi). However, we detected a significant decrease in the percentage of a small population 217 of macrophages expressing CD206 (mannose receptor) (CD45+SiglecF-F4/80+CD206+) in 218 CCR1-/-mice ( Fig. 6aii, bii) . Analysis of ACKR2-/-mice revealed a complimentary 219 phenotype to CCR1-/-mice in that they displayed an increase in the percentage of 220 macrophages in the mammary gland population and specifically of the CD206+ macrophage 221 subset ( Fig. 6cii) . 222
Finally, we examined the effects of estrogen on the CD206+ macrophage population. Our 223 data show that CCR1 expression was also increased on the surface of CD206+ 224 macrophages in response to both 17β-estradiol and the estrogen mimic Bisphenol A (BPA) 225 ( Fig. 6d ). No effect of estrogen on CCR1 expression was observed in male macrophages 226 ( Fig. 6d) . 227
Thus, a key population of CD206+ macrophages are reciprocally regulated by ACKR2 and 228 CCR1. Importantly, CD206+ mammary gland macrophages have previously been implicated 229 in branching morphogenesis (Jäppinen et al., 2019) and we propose that ACKR2 and CCR1 230 reciprocally control this population to coordinate branching morphogenesis in the pubertal 231 mammary gland. 232 233 CCL7 regulates CD206+ macrophages and branching morphogenesis. 234
Of the chemokines detected within the mammary gland, CCL7 is of particular interest as it is 235 shared between CCR1 and ACKR2 (Fig. 1) , and is elevated in the pubertal mammary glands 236 of ACKR2-/-mice ( Fig. 5aiv) (Wilson et al., 2017) . In addition, qRT-PCR analysis also 237 revealed that CCL7 is transcribed, by purified F4/80+ cells, at higher levels than other 238 ACKR2 ligands (Fig. 7ai ). We therefore investigated its expression and function in the 239 mammary gland. Using flow cytometry, intracellular staining revealed that CCL7 is produced 240 by immune cells, including SiglecF+ eosinophils, SiglecF-F4/80+ macrophages, and 241
SiglecF-Ly6C+ monocytes (Fig. 7aii ). For each cell type, a markedly higher percentage of 242 cells obtained from the female mammary gland produced CCL7, than from male fat pad 243 cells. Notably, around 60% of female SiglecF+ cells produced CCL7 compared with 10% of 244 male cells (Fig. 7aii ). The percentage of CCL7+ cells was unaffected in the absence of 245 ACKR2 (Fig. 7ai, ii) . CCL7 is also produced by CD45-epithelial cells: mature (EpCAM+ 246
CD49f-) and progenitor luminal (EpCAM+ CD49f+), and basal (EpCAM -CD49f+) cells ( Fig.  247 7aiii, Supplementary Fig. 4b ). Further, bioinformatic analysis confirmed that CCL7 is 248 produced by epithelial cells, including basal, luminal and myoepithelial cells (Supplementary 249 Given the notable CCL7 expression in the mammary gland, we next directly tested its 251 potential role in mammary gland development. PBS or 2 µg of CCL7 was administered 252 subcutaneously at the site of the mammary fat pad at the key time point of 6 weeks. After 3 253 days, mammary glands were harvested for cellular analysis by flow cytometry and carmine 254 alum whole-mount analysis. CCL7 administration alone was sufficient to increase the 255 percentage of CD206+ macrophages, and the area of branching within the mammary gland 256 ( Fig. 7b ). These data confirm that elevated levels of CCL7, as observed in ACKR2-/-mice, 257 leads to increased numbers of CD206+ macrophages in the mammary gland and 258 accelerated branching. 259
Overall these data demonstrate a role for CCL7, a ligand shared by CCR1 and ACKR2, in 260 branching morphogenesis. Lending further support to this conclusion is the fact that 261 revealed a previously unknown immunological mechanism whereby, ACKR2 and the 274 inflammatory chemokine receptor CCR1, interact with their shared ligand CCL7 to 275 coordinate the levels of CD206+ macrophages, and thus, the extent of branching 276 morphogenesis in the pubertal mammary gland. Importantly, administration of CCL7 alone 277 was able to increase the percentage of CD206+ macrophages within the mammary gland 278 and drive accelerated branching morphogenesis. We propose that in CCR1-/-mice, although 279 CCL7 levels are unaltered, macrophages are unable to sense and respond to the ligand 280 without the cognate receptor, leading to delayed branching (Fig. 8) . 281
Previously, it was thought that all mammary gland macrophages, at rest, and in 282 pathology, were derived from the bone marrow (Coussens and Pollard, 2011) . In our 283 previous study, we showed that branching was unaltered in the absence of CCR2, indicating 284 that the macrophage population responsible for promoting branching morphogenesis was 285 unlikely to be bone marrow derived (Wilson et al., 2017) . Recently, a novel CD206+ 286 macrophage population has been identified in the mammary gland, which is unaffected in 287 the absence of CCR2, but reduced in plvap-/-mice, which have reduced numbers of foetal-288 expression has also been described in placental development, there could be wider 303 implications of the interaction described in this study. 304
In the mouse, sexual maturity occurs at around 6 weeks (Topper and Freeman, 305 1980 ). Here we report a marked increase in plasma estradiol levels between 6.5 and 7 306 weeks. This is the key time point in ACKR2/CCR1-dependent regulation of branching 307 morphogenesis. ACKR2 expression in the mammary gland specifically peaks at 6.5 weeks 308 and branching begins to accelerate at this time point (Wilson et al., 2017) . We show that 309 17β-estradiol increases CCR1 expression on macrophages. However, this is restricted to 310 pubertal mammary gland macrophages, as older female, male and peritoneal macrophages 311 do not respond. In addition to 17β-estradiol, the estrogen mimic, Bisphenol A also increased 312 CCR1 expression on CD206+ macrophages. This may be of concern as BPAs are widely 313 found in the environment and could potentially alter the immune response, and the extent of 314 branching in the mammary gland, in children during puberty. Previously CCR1 expression on 315 T cells was shown to be regulated by 17β-estradiol (Mo et al., 2005) . However this is the first 316 description of estrogen controlled CCR1 expression on macrophages. This observation 317 could have implications for our understanding of diseases where females exhibit increased 318 susceptibility. One example is rheumatoid arthritis, where CCR1 is also associated with 319 pathology (Katschke Jr. et al., 2001; van Vollenhoven, 2009) . 320
Understanding the molecular signals which guide the rate of branching 321 morphogenesis in the mammary gland is highly important. Precocious puberty is a condition 322 where puberty begins before the age of 8, with some girls developing breasts as early as 4. 323
This results from early activation of the gonadotropic axis, leading to accelerated growth and 324 bone maturation, but ultimately reduced stature (Carel et al., 2004) In this study, we have uncovered a novel mechanism by which estradiol upregulates CCR1 339 expression by pubertal mammary gland macrophages and stromal ACKR2 modulates levels 340 of CCL7, to control the movement of the CCR1+ macrophages to the ductal epithelium. 341
Overall therefore our data demonstrate that CCR1 and ACKR2 coordinately regulate 342 mammary gland branching morphogenesis. 
Carmine Alum Whole Mount 354
Carmine alum whole mounts were carried out as described previously (Wilson et al., 2017) . 355
Briefly, fourth inguinal mammary glands were fixed overnight in 10% neutral buffered 356 formalin (NBF) (Leica) at 4°C. Glands were dehydrated for 1 h in distilled water, followed by 357 70% ethanol and 100% ethanol before overnight incubation in xylene (VWR international). and 10 mM aluminium potassium sulphate (Sigma)). Tissue was dehydrated again before 361 overnight incubation in xylene. Finally, glands were mounted with DPX (Leica) and stitched 362 bright-field images at 10× magnification were taken using an EVOS FL auto2 microscope 363 (Thermofisher). Ductal elongation, and branched area from the lymph node, were measured 364 using ImageJ 1.52a (Schneider, Rasband and Eliceiri, 2012) . 5 x brightfield images were 365 obtained using the Zeiss Axioimager M2 with Zen 2012 software. The numbers of branches 366 and branch thickness were counted as the average from 3 measurements from 6 individual 367 fields of view (F.O.V.) from each whole mount. TEBs were counted as the average from at 368 least 2 F.O.V. from each whole mount. All samples were blinded before measurements were 369 taken. 370
RNAscope ® In situ hybridisation 371
Mammary glands were fixed in 10% neutral buffered formalin at room temperature for 24-36 372 hours before being dehydrated using rising concentrations of ethanol and xylene, and 373 paraffin embedded (Shandon citadel 1000 (Thermo Shandon). Tissue was sectioned onto 374 Superfrost plus slides (VWR) at 6 μm using a Microtome (Shandon Finesse 325 Microtome, 375 Thermo). Slides were baked at 60 o C for 1 h before pre-treatment. Slides were deparaffinised 376 with xylene (5 mins x 2) and dehydrated with ethanol (1 min x 2). Tissues were incubated 377 with Hydrogen peroxide for 10 mins at RT, then boiled in antigen retrieval buffer for 15 mins. 378
Slides were treated with protease plus for 30 mins at 40 o C. Slides were then hybridised 379 using the RNAScope® 2.5 Red Manual Assay (Advanced cell diagnostics) according to the 380 manufacturer's instructions using the Mm-Ccr1 and Mm-ACKR2 probes. Slides were 381 mounted in DPX (Sigma Aldrich) and imaged on an EVOS FL Auto2microscope. 382
Mammary gland digestion 383
The inguinal lymph node was removed from the fourth inguinal mammary gland, tissue was 384 chopped, and enzymatic digestion was carried out in a 37°C shaking incubator at 200 rpm 385 for 1 h, with 3 mg/ml collagenase type 1 (Sigma) and 1.5 mg/ml trypsin (Sigma) in 2 ml 386 Leibovitz L-15 medium (Sigma). The suspension was shaken for 10 s before addition of 5 ml 387 of L-15 medium supplemented with 10% foetal calf serum (Invitrogen) and centrifugation at 388 400 g for 5 min. Red blood cells were lysed using Red Blood Cell Lysing Buffer Hybri-Max 389 (Sigma) for 1 min and washed in PBS. Cells were washed in PBS with 5 mM EDTA, 390 resuspended in 2 ml 0.25% Trypsin-EDTA (Sigma) and incubated at 37°C for 2 min before 391 addition of 5 ml of serum-free L-15 containing 1 μg/ml DNase1 (Sigma) for 5 min at 37°C. L-392 15 containing 10% FCS was added to stop the reaction and cells were filtered through a 40 393 μm cell strainer before a final wash in FACS buffer (PBS containing 1% FCS and 5 mM 394 EDTA). 395
Flow cytometry 396
Antibodies were obtained from BioLegend and used at a dilution of 1:200: CD45 (30-F11), 397
CD11b (M1/70), F4/80 (BM8), SiglecF (S17007L), Ly6C (HK1.4), EpCAM (G8.8), 398
CD49f(GoH3), CCR1 (S10450E), and CD206 (C068C2) for 30 min at 4°C. Dead cells were 399 excluded using Fixable Viability Dye eFluor 506 (Thermo Fisher). Intracellular staining for 400 CCL7 was carried out using 1 in 100 biotinylated CCL7 antibody (R&D Systems) and 401
Strepdavidin BV605 (BioLegend) and eBioscience intracellular fixation and permeabilization 402 buffer. Flow cytometry was performed using an LSRII or Fortessa, (BDBiosciences) and 403 analysed using FlowJo V10. 404
Proteomic analysis 405
The inguinal lymph node was removed from the fourth inguinal mammary gland, tissue was 406 chopped, frozen in liquid nitrogen, crushed with a mortar and pestle, and resuspended in 407 dH2O containing protease inhibitors (Pierce). Protein levels were determined using a custom 408 designed Magnetic Luminex Multiplex assay (R&D Systems), as described in the 409 manufacturer's instructions, and read with a Bio-Rad Luminex-100 machine. Data was 410 normalised to the protein concentration of tissue samples, determined by a BCA assay 411 (Pierce). 412
Subcutaneous administration of CCL7 413 2 µg of CCL7 in 200 µl PBS (R&D Systems) was injected subcutaneously into mice at 6 414 weeks of age. After 3 days, mice were culled and mammary glands were excised and 415 processed for whole mount and cellular analysis. 416
17β-estradiol assays 417
Fourth inguinal mammary glands were digested to obtain single cell suspensions. Cells were 418 plated at 0.5-1 x 10 5 cells in a 96 well plate in L-15 media containing 5% FCS and exposed 419 to DMSO (vehicle control) or 50 ug/ml 17-β estradiol or Bis-phenol A (Sigma) for 1 h at 37°C, 420 5% CO2. The level of 17-β estradiol in plasma samples was determined using the Estradiol 421 parameter kit (R&D Systems) as described in the manufacturer's instructions. 422 
